Hoerter Steven L. sold 4,893 shares of MBX Biosciences, Inc. at $54.82 for −$268k on Nov 10, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Chairman, President and CEO
Chairman, President and CEO
Filed Nov 12, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$268,234.26Shares × reported price
Shares traded
4,893Common Stock
Price per share
$54.82Reported price. Read footnotes for ranges.
% of reported position traded
5.9%This security and ownership context
Holdings after
78,045Direct
Trade date
Nov 10, 2026Sell
Filed
Nov 12, 2026, 7:57 AM ET2-day reporting delay
Accession
0001193125-26-457015Code S · Transaction 398223
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 82,938 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

MBX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
MBX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 19, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −7.8%1w ago −4.7%1d ago −6.3%
Returns since7d30d90d180d1y

Footnotes in full

F1: The sales reported on this Form 4 represent shares of common stock sold by the Reporting Person to cover tax obligations in connection with the vesting of restricted stock units, pursuant to a mandatory sell-to-cover agreement between the Reporting Person and the Company. F2: The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $51.52 to $55.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: Shares held by the Steven L Hoerter Revocable Trust dated November 2, 2018, of which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.